FDA
approval
· 2017-05-23
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approves Sun Pharmaceutical's supplemental application for buprenorphine and naloxone, confirming continued approval/availability of this generic product fo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)